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Type VII collagen is the major component of anchor-
ing fibrils, structures within basement membranes be-
neath stratified squamous epithelium thought to me-
diate the adherence of the epidermis to the dermis of 
human skin. Type VII collagen has affinity for fibro-
nectin. The interaction between type VII collagen and 
fibronectin is mediated through the collagen-binding 
domain on the amino terminus of fibronectin. Hereto-
fore, the domain on the type VII collagen molecule 
T ype VII collagen is the major component of anchoring fibrils, wheat stack - shaped structures located beneath the lamina densa of the basement membranes lying beneath stratified squamous epithelium [1). The type VII collagen molecule has three identical alpha poly-
peptide chains. Each alpha chain consists of a central collagenous 
domain flanked by a 145-kDa non-collagenous amino-terminal do-
main (NC1) and a 30-kDa carboxyl-terminal domain (NC2) [2,3]. 
In skin, anchoring fibril formation is initiated when two type VII 
collagen molecules overlap their carboxyl-terminal domains to 
form an antiparallel dimer. Several anti parallel dimers then laterally 
aggregate to form anchoring fibrils [4). 
Hereditary and acquired forms of dystrophic epidermolysis bul-
losa (EB) comprise a group of mechano-bullous disorders character-
ized by skin fragility and subepidermal blisters that leave residual 
scars and milia [5). The paucity of anchoring fibrils in the inherited 
and acquired forms of EB [6,7) and the presence of autoantibodies 
against type VII collagen in epidermolysis bullosa acquisita (EBA) 
[8) suggest that anchoring fibrils and type VII collagen play an 
important role in maintaining epidermal-dermal adherence. The 
human gene that encodes for type VII collagen has been cloned 
[9-11). Recent studies have demonstrated a genetic linkage be-
tween the heritable dystrophic forms of EB and the type VII colla-
gen gene [12-14). 
Type VII collagen has an affinity for fibronectin [15], a dermal 
glycoprotein, and type IV collagen, a major component of basement 
membranes [16,17). Fibronectin's affinity for type VII collagen is 
mediated by the collagen-binding domain located at the amino ter-
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that binds to fibronectin was not known. In this study, 
we mapped the binding site of fibronectin to a specific 
subdomain of the triple helical collagenous region of 
type VII collagen, immediately adjacent to the small 
carboxyl terminal non-collagenous domain. This fi-
bronectin-binding site within the type VII collagen 
molecule lies between nucleotide residues 615 and 
1161. Keywords: basement membrane/protein interaction/ 
extracellular matrix.] Invest DermatoI103:637-641, 1994 
minus of the fibronectin molecule [15). In this study, we mapped 
the fibronectin-binding site within the type VII collagen alpha 
chain to a unique site within the triple helical collagenous domain 
immediately flanking the NC2 terminus. 
MATERIALS AND METHODS 
Preparation of Recombinant Type VII Collagen Fusion Proteins 
and Native Type VII Protein Fragments Fragments of type VII colla-
gen cDNA corresponding to fusion proteins 1,2,4,5, and 6a (designated as 
FP1, FP2, FP4, FPs, and FP6a in Fig lA) were generated by polymerase 
chain reaction [18]. Type VII collagen cDNA corresponding to fusion pro-
tein 3 (FP3 in Fig lA) was obtained by immunoscreening a keratinocyte 
cDNA library with an EBA patient's sernm [9]. The preparation, purifica-
tion, and characterization of the fusion proteins have been detailed previ-
ously [19]. Their essential characteristics are presented in Table I. Briefly, 
the type VII col1agen cDNAs encoding for specific domains were subcloned 
into a modified pGEX vector (gift from Dr. George Giudice, Medical Col-
lege of Wisconsin), and expressed in Escherichia coli (strain DHsa) as a 
glut.~thione-S-transferase/type VII col1agen fusion protein [19,20]. The fu-
sion proteins were purified 0 11 a glutathione agarose bead column (Sigma, St. 
Louis, MO) [19,20]. The correct orientation and reading frame of each 
cloned insert was ascertained via nucleotide sequencing of the cloningjnnc-
tions [21]. 
In some experiments, the fusion protein 6a (FP6a on Fig lA) was digested 
with bacterial collagenase [3] to remove the collagenous segment of the 
fusion protein, thus isolating the glutathione-S-transferase product and the 
non-collagenous carboxyl-terminal peptide, NC2 (FP6b on Fig tA). The 
completeness of the bacterial collagenase digestion was assessed by sodium 
dodecylsulfate - polyacrylamide gel electrophoresis (SDS-PAGE) [22]. 
To confirm the findings obtained by using the recombinant fusion pro-
teins, native rype VII collagen extracted by pepsin digestion [4] (Gibco BRL, 
Gaithersburg, MD) and, thus lacking the non-collagenous amino- and car-
boxyl-terminal domains, was used in the binding assay. 
Fibronectin Binding Assay with Immobilized Protein onto Nitro-
cellulose Paper Evaluation of the binding of fibronectin to rype VII 
collagen under denaturing conditions was performed in a manner similar to 
that of a Western blot. Briefl y, following SDS-PAGE [22] and nitrocellulose 
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Figure 1. Schematic representations. A) The positions of recombinant 
fusion proteins and other protein fragments of type VII collagen used for 
mapping of the libronectin binding site to type VII collagen. B) The cd (VII) 
collagen subdomain organization. The non-collagenous ammo-termmal 
(NC-l) domain consists of several subdomains with ho~ology to the carti-
lage matrix protein (cmp) . nine consecutive segments with homology to the 
fibronectin type III domains (FNI-9). a segment with homology to the A 
domain of von Willebrand factor (vwf-a). and a cysteine-proline rich region 
(C-P). The 39 - amino acid non-collagenous interruption in the centr~1 col-
lagenous domain (solid area) and the area of libronectll1 bmdll1g wlthll1 the 
collagenous domain of type VII collagen (slashed area) are also indicated. 
transfer [23]. the blotted fusion proteins were incubated with fibronectin 
(Gibco BRL) diluted in wash buffer (Tris-buffered saline. 0.1 % NP-40) at a 
concentration of 50 jlg/ml for 3 h at 25 °C. The bound libronectin was 
detected by polyclonal goat anti-human libronectin antibodies (Organon 
Teknika-Cappel. Durham. NC) followed by a horseradish peroxidase-con-
jugated anti-goat IgG (Organon Te~nika-Cappel. Durhml. NC) with a 
washing step between each antibody lllcubation. As a negative control. the 
blotted fusion proteins were not preincubated with libronectin but were 
subsequently developed as indicated above. 
The binding of libronectin to type VII collagen was also performed with-
out SDS under non-denaturing conditions. Type IV collagen (Collaborative 
Biomedical Products. Bedford. MA). laminin (Gibco BRL) pepsinized type 
VII collagen (Gibco BRL). or fusion proteins (2.5 and 5.0 JIg) were dotted 
onto nitrocellulose without boiling or denaturation by SDS. The nitrocellu-
lose membranes wer~ then incubated with fibronectin and developed as 
described above. 
Fibronectin Binding Assay as Determined by Enzyme-Linked Im-
munoas~ays The binding of libronectin to type VII collagen (Gibco BRL) 
and the fusion protein FP6a and FP6b were also determined by enzyme-
linked immunoassays (ELISA) as previously described [24]. All wells were 
coated overnight with 0.5 pmol of proteins in 0.1 M carbonate buffer. pH 
9.0. The wells were then blocked with bovine serum albumin (BSA) in 
phosphate-buffered sal~ne (PBS). 0.05% Tween-20. ~oated wells were sub-
sequently incubated with libronectlll at a concentratIOn of 1 mg/ ml to 15 
mg/ml for 2 h at 25°C. The binding offibronectin was detected using goat 
anti-human plasma libronectin (Organon Teknika-Cappel) followed by in-
cubation with alkaline phosphatase -conjugated anti-goat IgG (Organon 
Teknika-Cappel). Development by colorimetric reaction using p-nitro-
phenyl phosphate (Bio-Rad. Melville. NY) as substrate was measured by 
absorbance at 405 nm (Bio-Tek Instruments. Winooski. VT). 
To determine the effect of denaturation of type VII collagen on the 
binding of libronectin. the same experiment as described above was per-
formed except that the wells were coated overnight with proteins denatured 
by boiling in carbonate buffer for 5 min . 
0.. 
A. 
B. 
2.5 ug 
5 ug 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
& 
a. 
u. 
I-(f) 
(!) ~ u.. ~ u. 
v 
a. 
u. 
~ 
u.. 
M 
a. 
u.. 
.0 
<D 
a. 
u.. 
0.: 
u.. 
<1l 
<D 
a. 
u.. 
-200 
-116 
- 80 
- 49 
-32 
-27 
c: 
a. 'c 
'E 
~ > <1l .-J 
f',[) f',[) 
• 
Figure 2. Fibronectin binds to denatured and non-denatured type 
VII collagen immobilized onto nitrocellulose paper. A) Binding of 
libronectin to denatured type VII collagen recombinant fusion proteins 
(FPl-6a). bacterial collagenase digested FP6a (FP6b). glutathione transfer-
ase (GST). or pepsinized type VII collagen fragment (VIIP). GST is a con-
stant part of all the fusion proteins and serves as the carrier protein (see 
Materials alld Methods). B) Dot-blot analysis of libronectin binding to 2.5 JIg 
or 5 flg of non-denatured type VII collagen. recombinant fusion protein. 
collagenase-digested FP6a (FP6b). and pepsinized type VII collagen (Vn)P. 
Fibronectin binding to 5 flg of immobilized type IV collagen and laminin 
serve as positive and negative controls. respectively. NO. not done. 
To determine which domain oflibronectin bound to the type VII collage-
binding domain. identical parallel experiments were performed using chy-
motrypsin-digested libronectin fragments [25] (Gibco BRL). These libro-
nectin fragments consist of a 45-kDa amino terminus collagen-binding 
domain. a central 120-kDa cell-binding domain. and a 40-kDa carboxyl 
terminus heparan-binding domain. The binding of these fragments to non-
denatured FP6a was determined by ELISA. It was previously shown that the 
45-kDa fragment of chymotrypsin digested libronectin contains the colla-
gen binding site [IS]. 
To confirm that the binding of libronectin to type VII collagen was 
mediated by the collagen-binding domain of libronectin. denatured gelatin 
(Sigma) was used as a competitive agent. Denatured gelatin at concentration 
from 0 to 100 flg/ml was incubated simultaneously with libronectin in the 
binding assay. Bound libronectin was then detected by ELISA as described 
above. 
Table I. Characteristics of the Glutathione Transferase (GST)-Type VII Collagen Fusion Proteins· 
Fusion Protein 
FP1 
FP2 
FP3 
FP4 
FP5 
FP6a 
Cloning Site 
BamHI-EcoRI 
BamHI-EcoRI 
EcoRI-EcoRI 
EcoRI-EcoRi 
BamHI-EcoRi 
BamHI-EcoRI 
Amino Acid Position 
Molecular Weight 
NH COOH (kDa) 
SILRTLLPL EPPETPLAV 72 
ETPLAVPGL RHQILPGNT 52.5 
GGPMRHQIL SPGPQGPVG 93.5 
KGDSEDGAP PGSVPNVDR 72.5 
SVPNVDRLL APGGLAGDL 66.5 
GSPGKDGVP SQGTGTAQD 64 
• For each fusion protein. the cloning site in the pGEX vector. the amino acid position of the amino- and carboryl-terminal ends of the type VII collagen insert, and the predicted 
molecular weight of the GST - type VII collagen fusion protein arc indicated. See Lapiere et.1 [19] for further details about the preparation and purification of these fusion proteins. 
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Figure 3. Fibronectin binding to dena-
tured and non-denatured type vn col-
lagen as deterDlined by ELISA. 0.5 
pmol/well of denatured (solid triatlgle) and 
non-denatured (ope/l square) pepsinized 
human type VII collagen (AJ, fusion pro-
tein FP6a (B), FP6b (C) were coated over-
night in carbonate buffer. Bound libronec-
tin was detected by ELISA as described in 
Materials and Methods. DSA, rather than Ii-
bronectin, served as a negative control in 
the binding assay. Error bars, mean ± SD. 
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RESULTS 
Figure 1 demonstrates schematically the gene encoding for type 
VII collagen (Fig lB) and the fusion proteins (Fig lA) correspond-
ing to the cDNA gene segments. Table I details the amino acid 
position of the amino- and carboxyl-terminal ends of the type VII 
collagen segments, the predicted molecular weight of the uncleaved 
fusion proteins and the cloning sites of the cDNA inserts for each 
fusion protein. Commercially available human pepsinized type VII 
collagen lacks the NC1 and NC2 domains and comprises only the 
helical collagenous domain indicated in Fig lA as (VII)P. 
As shown in Fig 2, when pepsinized type VII collagen and the 
seven fusion proteins (FP1 through FP6b) are subjected to SDS-
PAGE, electrophoretically transferred to nitrocellulose paper, and 
incubated with a solution of fibronectin and fibronectin binding is 
detected with antibody, fibronectin binds directly to the pepsinized 
human type VII collagen [Fig 2A, lane marked (VII)P]. This prod-
uct of pepsinized type VII collagen lacks the non-helical, globular 
domains NCt and NC2. Fibronectin does not bind any of the fusion 
proteins except FP6a (Fig 2A). It is important to note that no 
fibronectin binding occurs with FP3, FP4, and FPS, which contain 
long stretches of the Gly-X-Y amino acids. Importantly, fibronec-
tin does not bind FP6b, which is the fusion protein equivalent of the 
NC2 domain without Gly-X-Y segments (Fig 2A). The fact that 
fibronectin binds to the pepsinized type VII collagen lacking the 
NCt and NC2 domains, does not bind to pure NC2 fusion protein 
(FP6b), and uniquely binds only to FP6a, which comprises NC2 
plus a small Gly-X-Y segment immediately amino to NC2, indi-
cates by deduction that the fibronectin binding domain is a Gly-X-
Y -containing segment that lies immediately adjacent to the NC2 
terminus. Although this segment is similar to FP4 and FPS, it must 
have unique properties that allow it to have affinity for fibronectin, 
because fibronectin does not bind to other collagenous segments or 
fusion proteins representing NC1 and NC2 domains. 
The experiments with immunoblotted proteins examine the 
binding of fibronectin to type VII collagen under denaturing condi-
tions because they have been subjected to SDS-PAGE. To examine 
fibronectin binding under non-denaturing conditions, pepsinized 
human type VII collagen (VII)P and fusion proteins were immobil-
ized to nitrocellulose paper in a dot-blot assay (Fig 2B) and/or 
subjected to an ELISA using proteins without denaturation (Fig 3). 
As shown in Figs 2B and 3, fibronectin binds to (VII)P and FP6a 
under non-denaturing conditions. Nevertheless, as demonstrated in 
Fig 3, fibronectin affinity for (VII)P and FP6a is greater when the 
species are denatured. Again, under non-denaturing conditions, fi-
bronectin fails to bind to fusion proteins corresponding to the non-
collagenous amino or carboxyl termini. Figure 3 also demonstrates 
that fibronectin binding to (VII)P and FP6a increases by increasing 
the concentration of fibronectin in the incubation solution and that 
this increased binding of fibronectin is saturable between 8 and 15 
,ug/ml in the ELISA (Fig 3). 
The binding of fibronectin to whole type VII collagen has been 
shown previously to be mediated via the amino terminal, collagen-
binding domain of fibronectin [15]. To determine that the colla-
gen-binding domain of fibronectin mediated the interaction with 
the identified type VII collagen fibronectin-binding domain, we 
performed identical ELISAs with the three fibronectin fragments 
[25] (amino terminal collagen binding domain, cell-binding do-
main, and carboxyl terminal heparan binding domain). As shown in 
Fig 4, the collagen-binding domain of fibronectin binds to FP6a 
with higher affinity than the cell-binding and heparan-binding do-
mains of fibronectin . 
To confirm the functional importance of the fibronectin colla-
gen-binding domain interacting with the type VII collagen fibro-
nectin-binding domain, gelatin competition experiments were per-
formed and the bound fibronectin determined by ELISA (Fig 5) . 
FP6a or type I collagen (0.5 pmol) were immobilized to the bottom 
of 96-well dishes. Fibronectin was then incubated with the inuno-
bilized proteins in the presence of gelatin or BSA at concentrations 
between a and 100 ,ug/ml. Bound fibronectin was then detected by 
completion of the assay as described in Materials and M ethods. As 
shown in Fig 5, the presence of gelatin inhibits the binding 
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of fibronectin to FP6a or type I collagen, whereas albumin has no 
effect. 
Fusion proteins alone in the presence of anti-fibronectin antibody 
under denaturing and non-denaturing conditions served as negative 
controls and did not show any reactivity. Therefore, fibronectin 
binding to type VII collagen species by immunoblot, dot-blot anal-
ysis, and ELISA demonstrated that fibronectin binds to a specific, 
collagenous Gly-X-Y domain immediately amino to the NC2 do-
main and by deduction corresponds to a specific subsequence of 182 
amino acid residues within the collagenous domain (Fig 1). This 
fibronectin-binding site within the type VII collagen molecule lies 
between nucleotide residues 615 and 1161 according to the nucleo-
tide sequence published by Greenspan [11]. This interaction is 
highly specific because fibronectin does not have affinity for any of 
the non-collagenous carboxy or amino termini or even for other 
segments of the collagenous domain. 
DISCUSSION 
In this study, we have demonstrated that fibronectin specifically 
binds type VII (anchoring fibril) collagen under both native and 
denaturing conditions. In accordance with Owens and Baralle [26] 
who mapped the collagen-binding site on fibronectin using fibro-
nectin fusion proteins, collagenous fusion proteins expressed in E. 
coli can be used in a similar fashion for the mapping of the fibronec-
tin-binding site on type VII collagen. Using a panel of collagenous 
fusion proteins expressed in bacteria, we mapped the fibronectin-
binding site within the type VII collagen alpha chain to a 182 amino 
acid sub-fragment of the collagenous domain that lies immediately 
adjacent to the NC-2 domain. We also demonstrated that this 182 
amino acid sub-fragment binds fibronectin via the gelatin or colla-
gen-binding domain of fibronectin. 
It has been shown that the binding site of fibronectin to type I 
collagen is within the same region of the molecule susceptible to 
cleavage by interstitial collagenase [27] . Fibronectin competes with 
interstitial collagenase for this region of type I collagen and protects 
the triple helix ftom the digestion by interstitial collagenase [28]. In 
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Figure 4. The collagen-binding domain of fibronectin mediates the 
interaction between type VII collagen and fibronectin. 0.5 pmol/well 
of FP6a were coated overnight in carbonate buffer. Fragments of fibronectin 
were then added at concentration from 0 to 1511g/ml. The 45-kOa colla-
gen-binding domain (open square), the 120-kOa cell-binding domain (open 
triangle) , and the 40-kOa heparan-binding domain (open circle) were used in 
the assay. Bound fibronectin fragments were detected by ELISA as described 
in Materials and Methods. The results are express as absorbance at 405 nm after 
subtraction of the nonspecific background as determined by the binding of 
the fragment to GST (gluthatione-S-transferase). Error bars, mean ± SO. 
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Figure 5. Gelatin competes with type VII collagen for binding to 
fibronectin. 0.5 pmol/well of fusion protein FP6a (lift) and type I collagen 
(right) were coated overnight in carbonate buffer. 0.5I1g/ml of fibronectin 
was simultaneously incubated with 0 to 100 I1g/ ml of gelatin (solid sqllare) or 
identical concentration of BSA (open sqllare). Bound fibronectin was then 
detected by ELISA as described in Materials and Met/lads. Error bars, mean ± 
SO. 
the case of type VII coll agen, the cleavage site for interstitial colla-
genase is close to the middle of the triple helical domain [29]. No 
cleavage site for interstitial collagenase has been reported within or 
close to the fibronectin-binding site reported in this study. There-
fore, unlike the interaction with type I collagen, fibronectin does 
not bind to the previously reported interstitial collagenase cleavage 
site of type VII collagen. Thus, the role of fibronectin in protecting 
the coll agenase cleavage site that occurs in type I collagen is not 
likely in type VII collagen. 
The role of the fibronectin - type VII collagen interaction is un-
known. One possibility is that this interaction is important for the 
adherence of the basement membrane and the overlying epidermis 
onto the papillary dermis. Fibronectin is known to self aggregate, 
and this property, along with its affinity for type VII collagen, may 
play a role in the assembly of type VII collagen molecules into 
antiparallel dimers and/or cross aggregation of these dimers into 
anchoring fibrils. Perhaps analogous to the protective role of fibro-
nectin on the digestion of type I collagen by interstitial collagenase, 
the fibronectin - type VII collagen interaction might protect type 
VII collagen from the degradation by proteolytic enzymes. It is well 
known that fibronectin's affinity for all collagens (except ascaris 
cuticle collagen) is enhanced by denaturation of the collagen 
[15,24,27]. The biologic relevance of this phenomenon is not 
known . 
Heritable dystrophic forms of epidermolysis bullosa have been 
linked to the gene encoding type VII collagen [13,14]. Understand-
ing the function of type VII collagen and the specific domains 
within it will provide insights into the understanding of the patho-
genesis of blisters in inherited and acquired forms of dystrophic 
epidermolysis bullosa. In this context, it is important to determine 
the interactions of type VII collagen with other matrix molecules 
within the papillary dermis and the basement membrane zone. 
Moreover, it also is of interest that the first mutation detected in 
recessive dystrophic epidermolysis bullosa is a methionine-to-Iysine 
substitution within the NC-2 domain adjacent to the fibronectin 
binding site [30]. 
This stlldy was sllpported in part by NatiOlra/ltlstitlites oj Health grants R01-
AR33625, P01-AR41045, P01-AR38923, and T32-AR7561. 
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